We explored the contribution of stage at diagnosis to ethnic disparities in cancer survival in New Zealand. We linked 115811 adult patients with invasive cancer registered on the cancer registry 
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The ethnic mix of the more than 4 million people of New Zealand includes the indigenous Maori (15% of the population) and Pacific Islanders (7%), originally from the South Pacific islands (hereafter referred to as Pacific people). The majority of non-Maori/ non-Pacific people are of European descent. The Treaty of Waitangi (1840) was a formal agreement between Maori hapu (subtribes) and the British Crown, which guaranteed equity between Maori and other New Zealand citizens. 1 Because health rights are implicit in the treaty, 2 the poor health status of Maori 3 can be considered a breach of their rights under the treaty. 4 Since 1980, ethnic disparities in cancer mortality have widened. 5 These inequalities cannot be explained by the differences in incidence 6, 7 and point to likely differences in access to and quality of health care. 8 The few studies that have examined ethnic inequalities in cancer survival in New Zealand 9-11 did not account for background (other cause) mortality rates. Our goal was to quantify the disparities and to estimate the magnitude of the contribution of stage of disease to these inequalities.
METHODS
Adult patients (aged 15 to 99 years) who had a cancer registered in the New Zealand Cancer Registry between July 1, 1994, and June 30, 2002, were identified (n = 124 599). We restricted the analyses to 20 main sites (n= 118188) and excluded patients with (1) death certificate only registrations (n = 2345, 2.0%), (2) in situ cancer (n = 7, < 0.1%), or (3) a home address overseas (n = 25, < 0.1%).
We used the National Health Index, which uniquely identifies health care users, to obtain mortality data to June 2003. We used a Maori, Pacific, non-Maori/non-Pacific-prioritized system of assigning ethnicity 12 that is based on hospitalization and health administration data, as is standard in New Zealand. Patients with missing ethnicity data (2.6%) were analyzed with the non-Maori/non-Pacific group. We used SURV3 software 13 to estimate relative survival rates (RSRs) 14 
RESULTS
Among 115 811 patients, site-specific 5-year RSRs (Table 1) showed lower survival for Maori than for non-Maori/non-Pacific people at many sites, including cancer of the breast, cervix, colon/rectum, lung, prostate,  RESEARCH AND PRACTICE  and uterus. Ovarian cancer survival was higher in Maori compared with non-Maori/ non-Pacific women. Survival among Pacific people was lower than non-Maori/non-Pacific people for colorectal, breast, and cervical cancer and higher for lung cancer. There were no differences by gender (results not shown).
The survival pattern among the patients with missing stage data (35%) differed by site, but age-standardized RSRs were similar between the total population and those patients with recorded stage data (Tables 1  and 2 ). Following standardization for stage, the RSRs for Maori and non-Maori/ non-Pacific people were close for cancers of the breast and prostate. However, stage at diagnosis explained little of the survival disparities for cancers of the bladder, cervix, colorectum, head/neck/larynx, lung, or uterus. The apparent survival advantage among Maori for ovarian cancer was fully explained by stage.
DISCUSSION
Stage at diagnosis explains some but not all of the ethnic differences in cancer survival in New Zealand. Residual confounding through inaccuracies in stage classification could explain some of the results. Although little bias appears to have been introduced through exclusion of people with missing stage data. Differential access to health services and health system factors are likely to contribute to the remaining disparities.
Because cancer and death registration are mandatory, selective underascertainment is unlikely to explain the results. Using prioritized ethnicity, misclassification of Maori and Pacific ethnicity 19 would underestimate the differences in survival between ethnic groups. Selective migration of terminally ill Pacific cancer patients to the Pacific would artificially inflate their survival rate, which may explain some of our results. Higher comorbidities in Maori, which could limit treatment options, might account for some of the observed differences. Biological or genetic differences cannot account for ethnic differences in health. 20 The unequal distribution of socioeconomic position by ethnicity may explain some, but probably not all, [21] [22] [23] of the survival differences.
In the United States, similar outcomes are experienced by people of different ethnicities in equal-access settings 24 ; in other settings, the quality of cancer treatment differs by ethnicity. 8 Health care utilization by Maori is not proportional to the expected need, 3 which suggests that Maori are medically underserved in New Zealand. 25 Factors that influence the receipt of optimal health care include cost, 26 18 95% CI = 95% confidence interval; RSR = 5-year relative survival rate, estimated using ethnic-specific life tables; RSRR = Maori to non-Maori/non-Pacific RSR ratio. Analysis based on all patients with stage data recorded on the New Zealand Cancer Registry, n = 68 581.This table excludes leukemia and nonHodgkin's lymphoma, because surveillance, epidemiology, and end results (SEER) summary staging data are not available for these sites. a CI not included because data corresponds to a single individual.
To tackle these documented inequalities, it is necessary to pinpoint where on the cancer continuum inequalities arise. Survival disparities also could be reduced by addressing structural and service barriers within the health sector and by ensuring a commitment, with sufficient funding, to strengthen the Maori and Pacific health workforces. 
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